Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
Authors:
Open Access
- 1 July 2013
- journal article
- review article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 7, 653-666
Abstract
Peer reviewed article authored by (Al-Shakarchi I, Gullick NJ, Scott DL). Read article or submit your manuscript for publishing.Keywords
This publication has 48 references indexed in Scilit:
- Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)Annals of the Rheumatic Diseases, 2013
- Cost-Effectiveness Modelling of Sequential Biologic Strategies for the Treatment of Moderate to Severe Rheumatoid Arthritis in FinlandThe Open Rheumatology Journal, 2012
- The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid ArthritisArthritis, 2011
- Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritisTherapeutics and Clinical Risk Management, 2010
- Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptorRheumatology, 2009
- Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension studyAnnals of the Rheumatic Diseases, 2009
- Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapyModern Rheumatology, 2008
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialThe Lancet, 2008
- Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumabAnnals of the Rheumatic Diseases, 2007
- Evolving concepts of rheumatoid arthritisNature, 2003